The introduction of nicotinamide like a nicotine alternative in e-cigarette and smokeless products represents a substantial regulatory obstacle for your FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is known to act as a sedative at substantial dosages6. The statements produced by Nicotine River, ECBlend, and also other dist… Read More